Erwin Wang
Research Subjects
Erwin Wang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Bret Rudy
For more information on this article, contact Erwin Wang at [ protected
2 shared publicationsJoseph Weisstuch
For more information on this article, contact Erwin Wang at [ protected
2 shared publicationsAditya Samaroo
For more information on this article, contact Erwin Wang at [ protected
1 shared publicationFrank Volpicelli
NYU Langone Health, Brooklyn, New York
1 shared publicationLeora Horwitz
NYU Langone Health, Brooklyn, New York
1 shared publicationSimon Jones
NYU Langone Health, Brooklyn, New York
1 shared publication
Latest Publications
- 15 October 2024
- Published by Wolters Kluwer Health in Journal for Healthcare Quality
- Vol. 46 (6) , 370-379
The Use of a Single Risk Assessment Tool for Mortality and Numerous Hospital-Acquired Conditions
Quality assessment organizations leverage numerous patient safety measures to evaluate hospital performance, resulting in significant financial, administrative, and operational burdens on health systems. Low-intensity approaches that allow for reliable risk stratification of patients can reduce the required investment. The Braden score is a routinely performed bedside nursing evaluation validated to assess risk for hospital-acquired pressure injury. We hypothesized that the tool can be used to evaluate risk for other hospital-related adverse outcomes, including mortality, catheter-associated urinary tract infection (CAUTI), and central line–associated bloodstream infection (CLABSI). We found that abnormal Braden scores have significant association with numerous adverse outcome measures, including mortality, CLABSI, CAUTI, and iatrogenic hypoglycemia. Because of its frequency of reevaluation, we have found preliminary evidence that leveraging this tool can reduce harm by quickly identifying the most at-risk patients for various types of iatrogenic harm. We conclude that in the face of increasing automation and technical applications, for example, artificial intelligence–driven tools, highly reliable clinician bedside physical examination and evaluation can still have significant, low-cost, and high-value impact in improving patient safety.
- 15 October 2024
- Published by Wolters Kluwer Health in Journal for Healthcare Quality
- Vol. 46 (6) , 370-379
The Use of a Single Risk Assessment Tool for Mortality and Numerous Hospital-Acquired Conditions
Quality assessment organizations leverage numerous patient safety measures to evaluate hospital performance, resulting in significant financial, administrative, and operational burdens on health systems. Low-intensity approaches that allow for reliable risk stratification of patients can reduce the required investment. The Braden score is a routinely performed bedside nursing evaluation validated to assess risk for hospital-acquired pressure injury. We hypothesized that the tool can be used to evaluate risk for other hospital-related adverse outcomes, including mortality, catheter-associated urinary tract infection (CAUTI), and central line–associated bloodstream infection (CLABSI). We found that abnormal Braden scores have significant association with numerous adverse outcome measures, including mortality, CLABSI, CAUTI, and iatrogenic hypoglycemia. Because of its frequency of reevaluation, we have found preliminary evidence that leveraging this tool can reduce harm by quickly identifying the most at-risk patients for various types of iatrogenic harm. We conclude that in the face of increasing automation and technical applications, for example, artificial intelligence–driven tools, highly reliable clinician bedside physical examination and evaluation can still have significant, low-cost, and high-value impact in improving patient safety.
- Open Access
- 6 January 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (1) , e2142382
Quality and Safety Outcomes of a Hospital Merger Following a Full Integration at a Safety Net Hospital
The rate of hospital consolidation has more than doubled since 2009.1 Evidence suggests an overall negative effect of mergers on quality. Most studies show increased overall mortality following decreased hospital competition.2-5 A more recent study suggests overall mortality and readmission rates do not improve with hospital mergers and patient experience may worsen, even in consolidations with high-quality acquirers.6
- 6 January 2022
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (1) , e2142382
Open AccessQuality and Safety Outcomes of a Hospital Merger Following a Full Integration at a Safety Net Hospital
The rate of hospital consolidation has more than doubled since 2009.1 Evidence suggests an overall negative effect of mergers on quality. Most studies show increased overall mortality following decreased hospital competition.2-5 A more recent study suggests overall mortality and readmission rates do not improve with hospital mergers and patient experience may worsen, even in consolidations with high-quality acquirers.6